Five-Year Incidence of Progression to Ankle Osteoarthritis in Patients with and without Glucagon-like Peptide-1 Receptor Agonist Therapy
Ysa Le(Johns Hopkins University), Amiethab A. Aiyer(University of Miami), Zaid Elsabbagh(Apple (Israel)), Sudarsan Murali(Johns Hopkins University), Nigel Hsu(Apple (Israel)), Rahi Patel(University of California, Los Angeles), Jonathan Sayegh(University of Arizona)
Cited by 0
Related Papers
2018 International Consensus Meeting on Musculoskeletal Infection: Research Priorities from the General Assembly Questions
|Journal of Orthopaedic Research®|2019|313
Reimbursement for Orthopaedic Surgeries in Commercial and Public Payors: A Race to the Bottom
|Journal of the American Academy of Orthopaedic Surgeons|2021|39
Does use of glucagon-like peptide-1 agonists increase perioperative complications in patients undergoing shoulder arthroplasty?
|Journal of Shoulder and Elbow Surgery|2024|24
Preference-Signaling During the Orthopaedic Surgery Residency Application Process
|Journal of the American Academy of Orthopaedic Surgeons|2022|17